|
|
calcium ion transport
|
GO:0006816 |
159 |
0.419
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.387
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.281
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.269
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.241
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.212
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.185
|
Mouse |
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.182
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.159
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.154
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.152
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.151
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.147
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.146
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.145
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.137
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.136
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.132
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.132
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.128
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.126
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.125
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.123
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.120
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.118
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.118
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.118
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.118
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.117
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.116
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.113
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.112
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.111
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.111
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.106
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.106
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.106
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.104
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.102
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.099
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.098
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.098
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.095
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.091
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.090
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.090
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.089
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.089
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.089
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.086
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.085
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.084
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.083
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.082
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.082
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.082
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.081
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.081
|
|
|
|
positive regulation of catecholamine secretion
|
GO:0033605 |
2 |
0.080
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.080
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.079
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.079
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.078
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.077
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.076
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.076
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.076
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.075
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.075
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.074
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.074
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.071
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.071
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.071
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.071
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.071
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.070
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.069
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.069
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.069
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.068
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.068
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.067
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.067
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.067
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.065
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.065
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.064
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.064
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.062
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.062
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.062
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.062
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.061
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.061
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.060
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.060
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.060
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.060
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.060
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.059
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.059
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.058
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.058
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.057
|
|
|
|
circadian sleep wake cycle rem sleep
|
GO:0042747 |
1 |
0.057
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.057
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.057
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.057
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.057
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.056
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.055
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.055
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.055
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.054
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.054
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.053
|
|
|
|
positive regulation of dopamine secretion
|
GO:0033603 |
2 |
0.053
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.053
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.053
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.052
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.052
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.052
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.051
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.051
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.050
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.050
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.049
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.049
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.048
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.048
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.047
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.047
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.047
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.046
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.046
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.045
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.045
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.045
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.045
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.045
|
|
|
|
response to amphetamine
|
GO:0001975 |
16 |
0.044
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.044
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.043
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.043
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.043
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.043
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.042
|
|
|
|
baroreceptor response to decreased systemic arterial blood pressure
|
GO:0001982 |
2 |
0.042
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.042
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.042
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.042
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.041
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.041
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.041
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.041
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.040
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.040
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.040
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.040
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.039
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.039
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.039
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.039
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.039
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.038
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.038
|
|
|
|
catecholamine transport
|
GO:0051937 |
21 |
0.038
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.038
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.038
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.038
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.037
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.037
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.037
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.037
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.037
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.037
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.037
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.037
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.036
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.036
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.036
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.035
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.035
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.035
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.035
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.035
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.035
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.035
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.035
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.034
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.034
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.034
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.034
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.034
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.034
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.034
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.033
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.033
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.033
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.033
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.033
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.033
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.033
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.033
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.033
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.033
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.033
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.032
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.032
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.032
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.032
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.032
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.032
|
|
|
|
positive regulation of high voltage gated calcium channel activity
|
GO:1901843 |
1 |
0.032
|
|
|
|
positive regulation of exit from mitosis
|
GO:0031536 |
1 |
0.032
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.032
|
|
|
|
lung pattern specification process
|
GO:0060432 |
1 |
0.031
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.031
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.031
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.031
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.031
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.031
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.031
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.030
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.030
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.030
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.030
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.030
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.030
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.029
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.029
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.029
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.029
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.029
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.028
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.028
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.028
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.028
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.028
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.028
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.028
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.028
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.028
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.028
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.028
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.027
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.027
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.027
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.027
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.027
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.027
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.027
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.026
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.026
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.026
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.026
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.026
|
|
|
|
bronchiole morphogenesis
|
GO:0060436 |
1 |
0.026
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.026
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.026
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.026
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.026
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.025
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.025
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.025
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.025
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.025
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.025
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.025
|
|
|
|
regulation of circadian sleep wake cycle non rem sleep
|
GO:0045188 |
1 |
0.025
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.025
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.025
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.025
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.025
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.025
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.024
|
|
|
|
auditory receptor cell differentiation
|
GO:0042491 |
37 |
0.024
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.024
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.024
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.023
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.023
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.023
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.023
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.023
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.023
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.023
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.023
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.023
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.023
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.023
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.023
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.022
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.022
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.022
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.022
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.022
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.022
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.022
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.022
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.022
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.022
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.022
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.021
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.021
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.021
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.021
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
21 |
0.021
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.021
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.021
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.021
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.021
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.021
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.021
|
|
|
|
white fat cell proliferation
|
GO:0070343 |
2 |
0.021
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.021
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.021
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.021
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.021
|
|
|
|
positive regulation of heart rate
|
GO:0010460 |
10 |
0.020
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.020
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.020
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.020
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.020
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.020
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.020
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.020
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.020
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.020
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.020
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.020
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.020
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.020
|
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
23 |
0.020
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.020
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.020
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.020
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.020
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.020
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.019
|
|
|
|
regulation of circadian sleep wake cycle rem sleep
|
GO:0042320 |
1 |
0.019
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.019
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.019
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.019
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.019
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.019
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.019
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.019
|
|
|
|
positive regulation of growth hormone secretion
|
GO:0060124 |
3 |
0.019
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.019
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.019
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.019
|
|
|
|
submandibular salivary gland formation
|
GO:0060661 |
1 |
0.019
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.019
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.019
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.019
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.018
|
|
|
|
substantia nigra development
|
GO:0021762 |
2 |
0.018
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.018
|
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.018
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.018
|
|
|
|
intracellular distribution of mitochondria
|
GO:0048312 |
1 |
0.018
|
|
|
|
regulation of catecholamine secretion
|
GO:0050433 |
12 |
0.018
|
|
|
|
negative regulation of macrophage apoptotic process
|
GO:2000110 |
3 |
0.018
|
|
|
|
neural nucleus development
|
GO:0048857 |
22 |
0.018
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.018
|
|
|
|
trophoblast giant cell differentiation
|
GO:0060707 |
15 |
0.018
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.018
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.018
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.018
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.018
|
|
|
|
hexose transmembrane transport
|
GO:0035428 |
7 |
0.018
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.018
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.018
|
|
|
|
circadian sleep wake cycle non rem sleep
|
GO:0042748 |
2 |
0.018
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.018
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.018
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.018
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.018
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.018
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.018
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.018
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.017
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.017
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.017
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.017
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.017
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.017
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.017
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.017
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.017
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.017
|
|
|
|
positive regulation of inositol phosphate biosynthetic process
|
GO:0060732 |
2 |
0.017
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.017
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.017
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.017
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.017
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.017
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.017
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.017
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.017
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.017
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.017
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.017
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.017
|
|
|
|
deltoid tuberosity development
|
GO:0035993 |
3 |
0.017
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.016
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.016
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.016
|
|
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
45 |
0.016
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.016
|
|
|
|
synaptic transmission involved in micturition
|
GO:0060084 |
3 |
0.016
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.016
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.016
|
|
|
|
lateral geniculate nucleus development
|
GO:0021771 |
1 |
0.016
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.016
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.016
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.016
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.016
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.016
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.016
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.016
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.016
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.016
|
|
|
|
prostate glandular acinus development
|
GO:0060525 |
12 |
0.016
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.016
|
|
|
|
positive regulation of notch signaling pathway
|
GO:0045747 |
18 |
0.016
|
|
|
|
mesenchymal cell differentiation involved in lung development
|
GO:0060915 |
2 |
0.016
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.016
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.016
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.016
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.016
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.016
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.016
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.015
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.015
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.015
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.015
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.015
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.015
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.015
|
|
|
|
lung proximal distal axis specification
|
GO:0061115 |
1 |
0.015
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.015
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.015
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.015
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.015
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.015
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.015
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.015
|
|
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.015
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.015
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.015
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.015
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.015
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.015
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.015
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.015
|
|
|
|
visual behavior
|
GO:0007632 |
45 |
0.015
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.014
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.014
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.014
|
|
|
|
carnitine transmembrane transport
|
GO:1902603 |
3 |
0.014
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.014
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.014
|
|
|
|
positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure
|
GO:0001988 |
1 |
0.014
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.014
|
|
|
|
response to food
|
GO:0032094 |
17 |
0.014
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.014
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.014
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.014
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.014
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.014
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.014
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.014
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.014
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.014
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.014
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.014
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.014
|
|
|
|
branch elongation involved in salivary gland morphogenesis
|
GO:0060667 |
2 |
0.014
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.014
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.014
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.014
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.014
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.014
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.014
|
|
|
|
corticotropin hormone secreting cell differentiation
|
GO:0060128 |
3 |
0.014
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.014
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.014
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.013
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.013
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.013
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.013
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.013
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.013
|
|
|
|
regulation of white fat cell proliferation
|
GO:0070350 |
2 |
0.013
|
|